4.7 Article

Robust expression of a bioactive mammalian protein in Chlamydomonas chloroplast

期刊

PLANT BIOTECHNOLOGY JOURNAL
卷 5, 期 3, 页码 402-412

出版社

BLACKWELL PUBLISHING
DOI: 10.1111/j.1467-7652.2007.00249.x

关键词

chloroplast genetic engineering; orally available biologics; protein therapeutics; recombinant protein expression in algae

资金

  1. NIGMS NIH HHS [R01 GM054659-07, R01 GM054659] Funding Source: Medline
  2. PHS HHS [A1059614] Funding Source: Medline

向作者/读者索取更多资源

We have engineered the chloroplast of eukaryotic algae to produce a number of recombinant proteins, including human monoclonal antibodies, but, to date, have achieved expression to only 0.5% of total protein. Here, we show that, by engineering the mammalian coding region of bovine mammary-associated serum amyloid (M-SAA) as a direct replacement for the chloroplast psbA coding region, we can achieve expression of recombinant protein above 5% of total protein. Chloroplast-expressed M-SAA accumulates predominantly as a soluble protein, contains the correct amino terminal sequence and has little or no post-translational modification. M-SAA is found in mammalian colostrum and stimulates the production of mucin in the gut, acting in the prophylaxis of bacterial and viral infections. Chloroplast-expressed and purified M-SAA is able to stimulate mucin production in human gut epithelial cell lines. As Chlamydomonas reinhardtii is an edible alga, production of therapeutic proteins in this organism offers the potential for oral delivery of gut-active proteins, such as M-SAA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据